Tories voted down amendement to protect NHS from any form of control outside the UK

Joined
1 Apr 2016
Messages
13,439
Reaction score
540
Country
United Kingdom
https://twitter.com/HouseofCommons/status/1285314836386242565

Looks like we won't be taking back control and the NHS will be on the table for a trade deal with the US.

Yesterday the Tories voted down an amendment which included

Protecting the NHS from so-called investor-state dispute settlements (ISDS) – clauses which allow foreign investors to sue national governments for any measures which harm their profits.

These ISDS cases take place in secret private arbitration courts away from the public.

Well done Brexiteers, well done indeed. You unfortunately were tricked into voting against your best interests, you and your kids will suffer.

So all that clapping for the NHS was just another empty gesture. Clapping for it whilst stabbing it in the back.
 
Last edited:
Sponsored Links
Just some costs differences of medicines.

Replace the headstone of a dog and the so many are up in arms. Government votes to let NHS be part of trade deal (even when they said it would not be) and its meh.

Hope you have deep pockets.


Actimmune:


US - $4360 p/vial

UK - £450 p/vial

Daraprim:

US - $7500 p/tablet

UK - £0.43 p/tablet

Chenodal:

US - $473 p/tablet

UK - £140 p/tablet

Firazyr:

US - $16234 p/syringe

UK - £1395 p/syringe
 
Sponsored Links
Yes I blame the Russians as well

Putins mafia type run state has an agenda

DIVIDE and Rule ;)

Any one steps out of line gets jailed or bumped off

We all need to be vigilante ;) reds under the beds scenario ;)

Couple of shifty looking characters mooching around here the other day

They looked like Russians to me ;)
 
If the UK are already paying so little for medicine, why would they agree to pay more?
 
Here is the actual bill, NEW Clause 17 put forward by Caroline Lucas and then put to Parliament by The Labour party. If it were enacted we would find current NHS consultants, GP Surgeries, MRI scanning Units etc etc that may not meet all of the red tape and "Explicit" clauses within it let alone any new ones that may or not be "foreign".

(1) Regulations under section 2(1) may make provision for the purpose of implementing an international trade agreement only if the conditions in subsections (2) and (3) are met in relation to the application of that agreement in any part of the United Kingdom.

(2) The condition in this subsection is that no provision of that international trade agreement in any way undermines or restricts the ability of an appropriate authority—

(a) to provide a comprehensive publicly funded health service free at the point of delivery,

(b) to protect the employment rights or terms and conditions of employment for public sectoremployees and those working in publicly funded health or care sectors,

(c) to regulate and maintain the quality and safety of health or care services,

(d) to regulate and control the pricing and reimbursement systems for the purchase of medicines or medical devices, or

(e) to regulate and maintain the level of protection afforded in relation to patient data, public health data and publicly provided social care data relating to UK citizens.

(3) The condition in this subsection is that the agreement—

(a) explicitly excludes application of any provision within that agreement to publicly funded health or care services,

(b) explicitly excludes provision for any Investor-State Dispute Settlement (ISDS) clause that provides, or is related to, the delivery of public services, health care, care or public health,

(c) explicitly excludes the use of any negative listing, standstill or ratchet clause that provides, or is related to, the delivery of public services, health care, care or public health,

(d) contains explicit recognition that an appropriate authority (within the meaning of section 4) has the right to enact policies, legislation and regulation which protects and promotes health,

public health, social care and public safety in health or care services, and

(e) prohibits the sale of patient data, public health data and publicly provided social care data.

(4) For the purposes of this section—

“negative listing” means a listing only of exceptions, exclusions or limits to commitments made by parties to the agreement;

“ratchet” in relation to any provision in an agreement means any provision whereby a party, if (after the agreement has been ratified) it has unilaterally removed a barrier in an area where it had made a commitment before the agreement was ratified, may not reintroduce that barrier, and

“standstill” in relation to any provision in an agreement means any provision by which parties list barriers which are in force at the time that they sign the agreement and undertake not to introduce any new barriers.—(Bill Esterson.)

This amendment would aim to protect the NHS and publicly funded health and care services in other parts of the UK from any form of control from outside the UK.

Brought up.

Question put, That the clause be added to the Bill
 
Just some costs differences of medicines.

Replace the headstone of a dog and the so many are up in arms. Government votes to let NHS be part of trade deal (even when they said it would not be) and its meh.

Hope you have deep pockets.


Actimmune:


US - $4360 p/vial

UK - £450 p/vial

Daraprim:

US - $7500 p/tablet

UK - £0.43 p/tablet

Chenodal:

US - $473 p/tablet

UK - £140 p/tablet

Firazyr:

US - $16234 p/syringe

UK - £1395 p/syringe

The very first item I checked (Daraprim) showed you exaggerated the US price by a factor of ten, actual cost is 750 p/tab, not $7500.
Of course, both the US and the UK use a generic version, cost in US $9.90 p/tab, cost in UK $0.66 p/tab. I couldn't be @rsed to check the rest.

Galahad, you're enough to make a Russian blush.
 
But.. the docs and nurses did get told of a pay rise today.... :whistle:
 
Just some costs differences of medicines.

Replace the headstone of a dog and the so many are up in arms. Government votes to let NHS be part of trade deal (even when they said it would not be) and its meh.

Hope you have deep pockets.


Actimmune:


US - $4360 p/vial

UK - £450 p/vial

Daraprim:

US - $7500 p/tablet

UK - £0.43 p/tablet

Chenodal:

US - $473 p/tablet

UK - £140 p/tablet

Firazyr:

US - $16234 p/syringe

UK - £1395 p/syringe
nobody cares. nhs bla bla.
over rated . over staffed. over funded. under performing .
biggest waste of public money on the entire planet.
 
nobody cares. nhs bla bla.
over rated . over staffed. over funded. under performing .
biggest waste of public money on the entire planet.

The NHS actually performs pretty well when judged against other countries:

The U.S. ranks 15th.
  • No. 8: Australia. ...
  • No. 7: Japan. ...
  • No. 6: United Kingdom. ...
  • No. 5: Germany. Best Health Care System Rank: 5. ...
  • No. 4: Norway. Best Health Care System Rank: 4. ...
  • No. 3: Sweden. Best Health Care System Rank: 3. ...
  • No. 2: Denmark. Best Health Care System Rank: 2. ...
  • No. 1: Canada. Best Health Care System Rank: 1.
The NHS is good value and it provides healthcare that is free at the point of service - if you don't care about that, think about what is the biggest cause of bankruptcies in the US (healthcare bills)

You need an ambulance in the USA: $2,000 for an emergency ambo and a few tests in hospital.
 
The very first item I checked (Daraprim) showed you exaggerated the US price by a factor of ten, actual cost is 750 p/tab, not $7500.
Of course, both the US and the UK use a generic version, cost in US $9.90 p/tab, cost in UK $0.66 p/tab. I couldn't be @rsed to check the rest.

Galahad, you're enough to make a Russian blush.

hahahahah

It wasn't even the first item on the list.

You must have wet yourself when it was a typo - it was supposed to be $750 and not $7500.

You must have also checked the other figures and then decided ah well.

Make sure you leave enough money for your kids and grandkids if they get ill.
 
Sponsored Links
Back
Top